Michela Gabaldo is the Head of Alliance Management & Regulatory Affairs at Fondazione Telethon in Milan supporting the 2 internal Scientific Institutes through the clinical development up to the registration and market access of the gene therapy programs developed internally and in partnership with Pharmaceutical industries. She has more than 19 years of experience in drug development spanning from chemicals up to ATMP. She joined Telethon in 2011 where she manages gene therapy projects at different stages of development ranging from preclinical, to clinical, to registration and market access. Winner of 2017 edition of TopRA Award in the Future category, Michela offers up to date knowledge of the most recent regulations in ATMPs and Orphans. She’s currently a member of the IRDIRC Technical Scientific Committee.